Zanidatamab plus chemotherapy delays progression or death in patients with untreated locally advanced or metastatic gastroesophageal adenocarcinoma.

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.

In this study, researchers aimed to characterize cardiometabolic risk factors and cardiovascular disease incidence in racially and ethnically underrepresented women with breast cancer.

(HealthDay News) — Email communications can increase clinician engagement with prescription drug monitoring programs (PDMPs), according to a study published online Dec 19 in JAMA Health Forum.

In May, the U.S. Food and Drug Administration (FDA) approved the first at-home cervical cancer screening tool, developed by Teal Health. The wand allows patients to collect a vaginal sample themselves ...

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

Investigators explored the association between baseline patient-reported fatigue and the risk adverse events in cancer treatment trials.

Researchers compared the safety and efficacy of BrECADD vs eBEACOPP, a standard regimen, in the newly diagnosed, advanced-stage classical HL setting. Researchers determined the BrECADD combination ...

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.

The American Cancer Society’s Report on the Status of Cancer Disparities in the United States examines disparities in cancer occurrence and outcomes, and analyzes the factors that contribute to these ...

In this retrospective cohort analysis, researchers aimed to identify key predictors of trial enrollment among cancer patients.

New CDC guidelines categorize childhood vaccinations into routine, high-risk, and shared clinical decision-making tiers.